Genenta Science SpA Sponsored ADR (GNTA) Price & Analysis

78 Followers

GNTA Stock Chart & Stats

$1.02

$0.22(4.52%)

At close: Jan 08 4:00 PM EST

$1.02

$0.22(4.52%)

Day’s Range― - ―

52-Week Range$0.55 - $10.00

Previous Close$5.5

Volume13.55K

Average Volume (3M)57.57K

Market Cap

$34.81M

Enterprise Value$32.66T

Total Cash (Recent Filing)$28.15M

Total Debt (Recent Filing)$7.60M

Price to Earnings (P/E)―

Beta0.25

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding48,216,858

10 Day Avg. Volume45,625

30 Day Avg. Volume57,571

Financial Highlights & Ratios

PEG Ratio0.12

Price to Book (P/B)1.14

Price to Sales (P/S)0.00

P/FCF Ratio-3.64

Enterprise Value/Market Cap938.21K

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-1.21B

Enterprise Value/Ebitda-5.58M

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Clinical ProgressThe company's lead asset, Temferon, is advancing in first-line glioblastoma and has expanded into metastatic renal cell carcinoma, showing progress in its clinical programs.

Regulatory ApprovalGenenta recently received approval from the Agenzia Italiana del Farmaco (AIFA) to initiate this Phase 1 study in mRCC.

Safety ProfileIn the Phase 1/2a trial for glioblastoma, Temferon has been well tolerated with no dose-limiting toxicities, highlighting its safety profile.

Bears Say

Revenue DelaysTimelines for commercialization of Temferon have been pushed back to 2028 in Europe and 2029 in the US, indicating potential delays in revenue generation.

Genenta Science SpA Sponsored ADR News

Genenta Science Fails to Secure Shareholder Approval for Corporate Name Change but Sticks to Industrial Pivot

An update from Genenta Science SpA Sponsored ADR ( ($GNTA) ) is now available. On October 8, 2026,...

2d ago

GNTA

Genenta Science Capital Increase Upheld as Milan Court Rejects Interim Challenge

Genenta Science SpA Sponsored ADR ( ($GNTA) ) has provided an announcement. On October 2, 2026, the Court...

8d ago

GNTA

Genenta Science notes Sophia High Tech contributes to Spring Assembly in VEGA-C

Genenta Science (GNTA) announced that Sophia High Tech, the Italian aerospace and defense manufacturer in which Genenta made...

1M ago

GNTA

Genenta Science Delays Vote on Corporate Name Change After Shareholder Pushback

Genenta Science SpA Sponsored ADR ( ($GNTA) ) has issued an announcement. Genenta Science S.p.A., a Milan-based biotech...

1M ago

GNTA

Genenta Science Accelerates Shift to Aerospace and Defense With Industrial Consolidation Strategy

Genenta Science SpA Sponsored ADR ( ($GNTA) ) just unveiled an update. Genenta Science is redefining itself as...

1M ago

GNTA

Genenta Science Shareholders Approve Major Capital Authorization and Reverse Split Plan

Genenta Science SpA Sponsored ADR ( ($GNTA) ) has provided an update. On July 29, 2026, Genenta Science...

3M ago

GNTA

Sophia unveils Roman robotic arm to inspect nuclear fusion machine operations

Sophia High Tech, backed by Genenta Science (GNTA), announced the unveiling of Roman, a robotic arm engineered to...

3M ago

GNTA

Genenta Science Regains Full Effectiveness of Corporate Purpose Amendment After Milan Court Ruling

Genenta Science SpA Sponsored ADR ( ($GNTA) ) just unveiled an announcement. Genenta Science S.p.A., a Milan-headquartered biotech...

3M ago

GNTA

Genenta Science Confirms New Board, Share Buyback and Closes Sòphia High Tech Deal

Genenta Science SpA Sponsored ADR ( ($GNTA) ) has shared an update. At its June 29, 2026 annual...

4M ago

GNTA

Genenta Science Faces Court-Ordered Suspension of Corporate Purpose Amendment While Voting Rights Reform Stands

An announcement from Genenta Science SpA Sponsored ADR ( ($GNTA) ) is now available. Genenta Science S.p.A. reported...

4M ago

GNTA

Genenta Science Sets CEO Severance Terms and Narrows Non-Compete in June 2026

Genenta Science SpA Sponsored ADR ( ($GNTA) ) has shared an announcement. On June 19, 2026, Genenta Science...

4M ago

GNTA

Genenta Calls June 29 Shareholder Vote on Name Change, Capital Moves and Reverse Split

Genenta Science SpA Sponsored ADR ( ($GNTA) ) just unveiled an update. Genenta Science has called an Ordinary...

4M ago

GNTA

Genenta Science enters binding offer to fund Sophia High Tech

Genenta Science (GNTA) announced that it has entered into a binding offer with Sophia High Tech, under which...

7M ago

GNTA

Genenta continues to evaluate options for original biotechnology platform

Genenta Science (GNTA) announced that, with respect to its biotechnology platform, Genenta has been and continues to be...

7M ago

GNTA

GNTA FAQ

What was Genenta Science SpA Sponsored ADR’s price range in the past 12 months?

Genenta Science SpA Sponsored ADR lowest stock price was $0.55 and its highest was $10.00 in the past 12 months.

What is Genenta Science SpA Sponsored ADR’s market cap?

Genenta Science SpA Sponsored ADR’s market cap is $34.81M.

When is Genenta Science SpA Sponsored ADR’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Genenta Science SpA Sponsored ADR’s earnings last quarter?

Currently, no data Available

Is Genenta Science SpA Sponsored ADR overvalued?

According to Wall Street analysts Genenta Science SpA Sponsored ADR’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Genenta Science SpA Sponsored ADR pay dividends?

Genenta Science SpA Sponsored ADR does not currently pay dividends.

What is Genenta Science SpA Sponsored ADR’s EPS estimate?

Genenta Science SpA Sponsored ADR’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Genenta Science SpA Sponsored ADR have?

Genenta Science SpA Sponsored ADR has 48,216,858 shares outstanding.

What happened to Genenta Science SpA Sponsored ADR’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Genenta Science SpA Sponsored ADR?

Currently, no hedge funds are holding shares in GNTA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Genenta Science SpA Sponsored ADR Stock Smart Score

Underperform

News Sentiment

Neutral

Bullish news 50%
Bearish news 50%

Technicals

Fundamentals

Return on Equity

-36.82%

Trailing 12-Months

Asset Growth

―

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Genenta Science SpA Sponsored ADR

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.